🔗 Share this article

Treasury head Rachel Reeves has stated she is preparing "focused measures to deal with cost of living pressures" in the forthcoming financial statement.

In comments to media outlets, she stated that lowering price rises is a collective task of both the administration and the Bank of England.

The United Kingdom's inflation rate is expected to be the most elevated among the G7 industrialized countries this calendar year and the following year.

Possible Energy Cost Measures

Reports indicate the administration could intervene to bring down energy bills, for example by cutting the current 5% rate of value-added tax charged on energy supplies.

An additional approach is to lower some of the government charges currently added to household expenses.

Fiscal Limitations and Expert Predictions

The administration will receive the latest report from the official forecaster, the OBR, on Monday, which will reveal how much scope there is for such measures.

The expectation from most analysts is that Reeves will have to introduce higher taxes or expenditure reductions in order to fulfill her declared borrowing rules.

Earlier on Thursday, analysis showed there was a £22 billion deficit for the Treasury chief to resolve, which is at the more modest range of projections.

"It is a shared responsibility between the Bank of England and the government to continue tackling some of the drivers of inflation," the Chancellor stated to reporters in the US capital, at the conferences of the IMF and global financial institution.

Tax Commitments and International Concerns

While much of the focus has been on likely tax rises, the chancellor said the latest figures from the fiscal watchdog had not altered her commitment to manifesto promises not to increase rates on earnings tax, sales tax or National Insurance.

She blamed an "unpredictable global environment" with growing international and trade issues for the fiscal revenue measures, likely to be targeted on those "wealthiest."

Global Trade Disputes

Commenting on concerns about the United Kingdom's commercial links with China she said: "The UK's security interests invariably take priority."

Recent statement by China to tighten trade restrictions on critical minerals and other resources that are crucial for high-technology manufacturing led American leader Donald Trump to suggest an extra 100% import tax on imports from the Asian country, raising the prospect of an full-scale commercial conflict between the two economic giants.

The US Treasury Secretary called the Chinese move "economic coercion" and "a international production control attempt."

Questioned on considering the American proposal to participate in its dispute with the Asian nation, Reeves said she was "extremely troubled" by Chinese actions and encouraged the Chinese government "to avoid restrictions and restrict access."

She said the decision was "harmful for the global economy and causes additional challenges."

"I believe there are fields where we must challenge Chinese policies, but there are also important chances to trade with China's economy, including banking sector and other sectors of the economic system. We've got to get that equilibrium correct."

The Treasury chief also affirmed she was collaborating with other major economies "on our own essential resources approach, so that we are reduced dependence."

NHS Medicine Costs and Investment

The Chancellor also admitted that the cost the National Health Service spends on pharmaceuticals could increase as a result of current negotiations with the US government and its drugs companies, in exchange for lower tariffs and investment.

Some of the world's largest drug companies have said in recent statements that they are either pausing or scrapping projects in the United Kingdom, with several blaming the modest returns they are getting.

Last month, the Science Minister said the cost the NHS spends on drugs would must go up to halt businesses and drug research funding leaving the United Kingdom.

The Chancellor informed the BBC: "We have seen due to the pricing regime, that medical research, new drugs have not been provided in the UK in the extent that they are in other European countries."

"The objective is to make sure that people getting care from the NHS are able to access the best essential drugs in the globe. And so we are reviewing all of that, and... aiming to obtain more investment into Britain."